APPLICATION
ANDA090887
TYPE
ANDA
ORIGINAL APPROVAL
2011-07-19
LATEST ACTION
2026-01-30
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
LATANOPROSTDiscontinued
LATANOPROST 0.005% · SOLUTION/DROPS · OPHTHALMIC
Approval history
2026-01-30Labeling · Supplement 16 · standardAP
2026-01-30Labeling · Supplement 17 · standardAP
2026-01-30Labeling · Supplement 15 · standardAP
2014-09-22Manufacturing (CMC) · Supplement 9AP
2011-07-19OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.